Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Weimer, Rolf [VerfasserIn]   i
 Zipperle, Silvia [VerfasserIn]   i
 Daniel, Volker [VerfasserIn]   i
 Opelz, Gerhard [VerfasserIn]   i
Titel:In vitro cytokine treatment of B cell defects in HIV-infected hemophilia patients
Verf.angabe:Rolf Weimer, Silvia Zipperle, Volker Daniel, Gerhard Opelz
E-Jahr:1995
Jahr:July 1995
Umfang:11 S.
Fussnoten:Gesehen am 22.08.2024
Titel Quelle:Enthalten in: Vox sanguinis
Ort Quelle:Oxford [u.a.] : Wiley-Blackwell, 1956
Jahr Quelle:1995
Band/Heft Quelle:69(1995), 1, Seite 27-37
ISSN Quelle:1423-0410
Abstract:HIV-infected patients exhibit defects in B cell differentiation and in the IL-6 response of B cells, in association with autoantibody formation against T cells. These autoantibodies have been implicated as important factors in the development of immunodeficiency disease. As the restoration of defective B cell responses might prevent autoantibody formation and the resulting immunosuppression, we studied whether in vitro treatment with recombinant IL-2 (rIL-2), recombinant IL-4 (rIL-4) or recombinant IL-6 (rIL-6) might restore the response of B cells of HIV-infected patients. B cells of 6 HIV-negative hemophilia patients, 4 HIV-positive patients at CDC stage II, III, 4 HIV-positive patients at CDC stage IV, and 6 healthy controls were tested in Staphylococcus aureus Cowan I (SAC-I)-stimulated B cell cultures and Pokeweed mitogen (PWM)-stimulated allogeneic B and T cell cocultures. B cell differentiation was assessed in a reverse hemolytic plaque assay and by ELISA determination of IgM, IgG and IL-6 in culture supernatants. In vitro application of rIL-6 resulted in suppression of both elevated unstimulated and mitogen-stimulated B cell responses in a dose-dependent manner which was in part due to feedback inhibition. PWM- and SAC-I-stimulated IgG and IgM responses, respectively, could be restored after addition of 10 U/ml rIL-2 in HIV-negative patients, but not in HIV-positive patients. Addition of rIL-4 to cultures resulted in suppression of both unstimulated and mitogen-stimulated IL-6 secretion and B cell responses. Severely depressed B cell responses in CDC IV patients were not significantly affected by cytokine application. These results indicate that defective Ig responses in HIV-negative patients may be restored by rIL-2 treatment whereas HIV-induced B cell defects are not corrected by supply of T cell help or cytokines promoting B cell growth and differentiation.
DOI:doi:10.1111/j.1423-0410.1995.tb00344.x
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1111/j.1423-0410.1995.tb00344.x
 Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1423-0410.1995.tb00344.x
 DOI: https://doi.org/10.1111/j.1423-0410.1995.tb00344.x
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1899376739
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69246399   QR-Code
zum Seitenanfang